Sai Life Sciences Limited has scheduled a meeting with a Goldman Sachs analyst and investor group in Hyderabad on June 11, 2026. The interaction will take place under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The company clarified that it does not intend to discuss any unpublished price sensitive information during the meeting.

The meeting is categorized as a group interaction. Sai Life Sciences noted that the schedule may undergo changes due to exigencies on the part of the analysts, investors, or the company. No new presentation is planned to be made during the session.

Sai Life Sciences Limited disclosed that its promoters and promoter group members did not encumber any shares directly or indirectly during the financial year ended March 31, 2026. This declaration was made by Krishnam Raju Kanumuri, a promoter of the company, in a filing submitted to the National Stock Exchange of India Limited and BSE Limited on April 07, 2026. The disclosure confirms that no new encumbrances were created beyond those previously reported during the financial year.

The filing was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to disclose any encumbrance of shares to ensure transparency in shareholding patterns. The document specified that the declaration covers the promoter and promoter group, including Persons Acting in Concert (PAC).

The submission included an exhaustive list of individuals and entities falling under the promoter and promoter group categories. The list comprises 48 entries, ranging from individual promoters to various partnership firms, private limited companies, and family trusts. Krishnam Raju Kanumuri signed the declaration on behalf of the promoters, promoter group, and PAC.

List of Promoters and Promoter Group

The following table details the entities classified as promoters and promoter group members as per the disclosure: